Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Synergistic combination of IL-4, interferon gamma, and interferon alpha in treating ovarian cancer

Synergistic combination of IL-4, interferon gamma, and interferon alpha in treating ovarian cancer

US Patent 10849960 · Granted Dec 1, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Interleukin-4 receptor-binding fusion proteins and uses thereof2025
Interleukin-4 receptor-binding fusion proteins and uses thereof2022
Interleukin-4 receptor-binding fusion proteins and uses thereof2021
Use of cysteamine and derivatives thereof to suppress tumor metastases2021
Targeted cargo protein combination therapy2017
Methods of treating and preventing inflammatory bowel disease involving IL-13 an2015
Chimeric molecule for the treatment of th2-like cytokine mediated disorders2009
Interferon alpha hybrids2007
Interferon &agr; hybrids2004
IL-13 receptor specific chimeric proteins and uses thereof2003
Compositions and methods for specifically targeting tumors2002
Circularly permuted ligands and circularly permuted chimeric molecules2000